Optical coherence tomography-angiographic vascular densities in Familial Mediterranean Fever (FMF) Patients with

Cemal Çavdarli1, Büsranur Çavdarli2, Pinar Topcu-Yilmaz1

  • 1Department of Ophthalmology, University of Health Sciences,Ankara Numune Training and Research Hospital , Ankara, Turkey.

Insights

Familial Mediterranean fever (FMF) patients with the M694V mutation show no significant differences in macular vessel density or foveal avascular zone parameters compared to healthy individuals. This suggests the M694V mutation does not impact retinal vasculature in FMF.

Area of Science:

  • Ophthalmology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
  • The M694V mutation in the MEFV gene is common in FMF and linked to amyloidosis.
  • Retinal vascular changes in FMF are not well-characterized.

Purpose of the Study:

  • To compare macular optical coherence tomography angiography (OCT-A) measurements between FMF patients with the M694V mutation and healthy controls.
  • To investigate potential impacts of the M694V mutation on retinal vasculature.

Main Methods:

  • Macular OCT-A was used to measure vessel densities (superficial and deep vascular plexuses, choriocapillaris), foveal avascular zone (FAZ) parameters, and non-flow areas.
  • Thirty-eight FMF patients with M694V mutations and 40 age- and sex-matched healthy controls were included.
  • Compound heterozygous pathogenic variants were excluded.

Main Results:

  • No statistically significant differences were found in any OCT-A parameters between the FMF and control groups.
  • Macular vessel densities, FAZ perimetry, foveal VD 300µ around the FAZ (FD-300), acirculatory index (AI), and non-flow area were comparable.
  • Age and gender distributions were similar between the groups.

Conclusions:

  • FMF patients with the M694V mutation do not exhibit significant differences in macular vascular density or FAZ parameters compared to healthy controls.
  • The M694V mutation may not directly cause detectable changes in retinal vasculature detectable by OCT-A.
  • Further research may explore other ocular manifestations or different genetic variants in FMF.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
367
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
253
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
144
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
342
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
142
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
660